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Abstract
Background: Culture-independent molecular analyses allow researchers to identify diverse 
microorganisms. This approach requires microbiological DNA repositories. The standard for DNA 
storage is liquid nitrogen or ultra-low freezers. These use large amounts of space, are costly to 
operate, and could fail. Room temperature DNA storage is a viable alternative. In this study we 
investigated storage of bacterial DNA using two ambient storage matrices, Biomatrica 
DNAstable® Plus and GenTegra® DNA.
Methods: We created crude and clean DNA extracts from five Streptococcus pneumoniae 
isolates. Extracts were stored at −30°C (our usual DNA storage temperature), 25°C (within the 
range of temperatures recommended for the products), and 50°C (to simulate longer storage time). 
Samples were stored at −30°C with no product and dried at 25°C and 50°C with no product, 
Biomatrica DNAstable® Plus, or GenTegra® DNA. We analyzed the samples after 0, 1, 2, 4, 8, 
16, 32, and 64 weeks using the Nanodrop 1000 to determine the amount of DNA in each aliquot 
and by qPCR for the S. pneumoniae genes lytA and psaA. Using a 50°C storage temperature, we 
simulated 362 weeks of 25°C storage.
Results: The average amount of DNA in aliquots stored with a stabilizing matrix was 
103%-116% of the original amount added to the tubes. This is similar to samples stored at −30°C 
(average 102%-121%). With one exception, samples stored with a stabilizing matrix had no 
change in lytA or psaA Ct value over time (Ct range ≤ 2.9), similar to samples stored at −30°C (Ct 
range ≤ 3.0). Samples stored at 25°C with no stabilizing matrix had Ct ranges of 2.2 – 5.1.
Conclusion: DNAstable® Plus and GenTegra® DNA can protect dried bacterial DNA samples 
stored at room temperature with similar effectiveness as at −30°C. It is not effective to store 
bacterial DNA at room temperature without a stabilizing matrix.
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Introduction
Biorepositories around the world need to store DNA for long periods of time. Currently, the 
gold standard for long-term storage of DNA samples is in liquid nitrogen (−196°C) or in 
ultra-low freezers with temperatures ranging from −20°C to −80°C. The systems required 
for this type of storage take up large amounts of space, are costly to operate, and are at risk 
of failure (1). A review published in 2007 estimated at that time the yearly global cost of 
maintaining frozen DNA samples probably exceeded $100 million (2).
Room temperature DNA storage is emerging as a viable alternative to frozen storage and 
recent publications have shown the effectiveness of some of the currently available 
commercial products (3–13). Two of these ambient storage products, Biomatrica 
DNAstable® Plus and GenTegra® DNA, use chemical compounds to protect DNA against 
oxidation and hydrolysis. In addition, when the DNA-chemical compound solution is dried, 
a physical barrier is created as the chemical compound forms a protective coating around the 
DNA.
The advent of culture-independent molecular analyses allows researchers to identify diverse 
microorganisms in an ecosystem. This type of work is undoubtedly leading to repositories of 
DNA from microbiological sources. Our laboratory’s primary need for long-term DNA 
storage is for genetic analysis of viral and bacterial organisms causing infectious diseases. 
We currently have a large repository of frozen bacterial isolates as well as DNA extracted 
from them, thus we are in a position of evaluate the usefulness of room temperature storage 
of bacterial DNA. In this study we investigated two long-term, ambient DNA storage 
matrices, Biomatrica DNAstable® Plus and GenTegra® DNA for the storage of bacterial 
DNA, and compared them to our current method of DNA storage, frozen at −30°C.
Materials and Methods
Creation and storage of DNA extracts
We retrieved from −70°C storage five isolates of Streptococcus pneumoniae (S. 
pneumoniae) bacteria representing serotypes 3, 7F, 8, 15B, and 22F, subcultured them onto 
Trypticase soy agar with 5% sheep blood (Remel, Lenexa, KS), and incubated them 
overnight at 37°C with 5% CO2. Using 1 μL loops, we then transferred bacterial cells to 3.0 
mL nuclease-free water and vortexed the suspensions to ensure uniformity. We heated the 
suspensions at 100°C for 10 minutes and centrifuged them at 13,000 rpm for 5 minutes. We 
removed the supernatant containing the crude DNA, setting aside half and further cleaning 
up the other half using the QIAamp DNA Blood Mini Kit’s purification from tissues 
protocol (Qiagen, Valencia, CA). This procedure allowed us to have two types of DNA 
preparations and from here forward we will refer to them as crude DNA and clean DNA, 
respectively.
Using a Nanodrop 1000 (Nanodrop, Wilmington, DE) we determined the amount of DNA in 
each of our five crude and clean DNA stocks. We dispensed ≤1.0 μg of each stock into 
1.25mL Sarstedt polypropylene tubes with o-ring seals. To ensure this amount of DNA was 
in each tube, sample volumes differed for aliquots of each stock. After dispensing the DNA 
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stocks into the tubes, DNA was stored with DNAstable® Plus (Biomatrica, San Diego, CA), 
with GenTegra® DNA (Pleasanton, CA), or with no stabilizing matrix (Figure 1). We treated 
DNA stored with DNAstable® Plus or with GenTegra® DNA as outlined in their respective 
product inserts (14, 15). In brief, DNAstable® Plus was used at one part matrix to four parts 
DNA sample; 5 μL of GenTegra® DNA was added regardless of DNA sample volume. We 
used a room temperature vacuum centrifuge (Labconco CentiVap, Kansas City, MO) to dry 
the samples. We stored the tubes at three temperatures: −30°C (our laboratory’s usual DNA 
storage temperature), 25°C (which is within the range of storage temperatures recommended 
by the product’s manufacturers), and 50°C (to simulate longer storage times than allowed for 
by this study) (16) (Table 1). To protect the dried DNA from becoming damaged by 
humidity and/or fluorescent light, all tubes were stored in opaque boxes that were placed in 
darkened incubators in rooms with low humidity (≤35%).
Testing of DNA extracts
We analyzed the samples after 0, 1, 2, 4, 8, 16, 32, and 64 weeks in storage. Using a 50°C 
storage temperature, we were able to simulate 362 weeks of 25°C storage (Table 1). A new 
aliquot was tested at each time point. At the time of testing, we reconstituted DNA stored 
dried with nuclease-free water to the same volume as the original, incubated the tubes at 
room temperature for at least 15 minutes, and gently mixed by pipetting. We determined 
DNA concentration, and subsequently total DNA, using the NanoDrop 1000; we tested for 
the S. pneumoniae genes lytA and psaA using real-time PCR (qPCR) (17). For each qPCR 
assay, we used a common positive control and adjusted the assay threshold to within +/− 2 
cycle threshold (Ct) values of a previously determined mean for that control.
Analysis
As we have no reason to believe DNA from different serotypes of S. pneumoniae will 
behave differently in storage, for analysis we combined data from the five isolates. This gave 
us a single value for each storage condition and time point. Information we received from 
the product’s manufacturers indicated their products had only been tested on clean DNA 
(personal communication), so we considered the crude DNA and clean DNA preparations as 
different samples. For the DNA yield analysis, we compared the DNA yield at all time 
points with the amount of DNA added to the tubes at time 0 and calculated an average 
percentage recovery for each storage temperature and condition. For the qPCR analyses, we 
compared the Ct value range across all time periods for each storage temperature and 
condition. We considered a Ct range of ≤3.0 cycles (~1 log10) to be the same (18).
Results
DNA yield(μg) over time for S. pneumoniae crude and clean DNA extracts stored at room 
temperature or −30°C with and without a stabilizing matrix are shown in Table 2. Compared 
with the amount of DNA added to the tubes at time 0, the average percent recovery for 
samples stored with a stabilizing matrix ranged from 103%-116% which is similar to that 
found for samples stored at −30°C (102% and 121%). Samples stored at room temperature 
without a stabilizing matrix showed an average percent recovery of 98% and 116% for the 
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crude and clean preparations, respectively. The >100% recovery is likely due to variances in 
Nanodrop 1000 measurements.
qPCR testing for the S. pneumoniae-specific gene, lytA, showed that samples stored with a 
stabilizing matrix had no change in Ct values over time (Ct range ≤ 2.3 cycles), similar to 
samples stored in our usual manner, −30°C (Ct range = 2.0 cycles; Table 3). Clean 
preparation samples stored without a stabilizing matrix had increase in Ct value over time 
(Ct range = 3.2 cycles) but the crude preparation samples did not (Ct range = 2.2 cycles).
Real time PCR testing for the S. pneumoniae-specific gene, psaA, showed that, with the 
exception of the clean preparation samples stored with DNAstable® Plus (Ct range = 3.1 
cycles), samples stored with a stabilizing matrix had no change in Ct values over time (Ct 
range ≤ 2.9 cycles; Table 4). This is similar to the Ct range for samples stored at −30°C (Ct 
range = 3.0 cycles). Both crude and clean preparation samples stored dried without a 
stabilizing matrix had a change in Ct value over time (Ct range ≥ 3.7 cycle).
Discussion
This study was designed to evaluate two DNA stabilizers, DNAstable® Plus and GenTegra® 
DNA, on the ambient storage of bacterial DNA extracted using crude and clean 
methodologies. As far as we know this is the first study that has investigated ambient 
temperature storage products on DNA from bacteria. This is an important addition to the 
literature since culture-independent technologies are leading to increased interest in 
microbiome studies. In turn, samples from these studies need to be stored as safety and 
efficiently as possible. Additionally, studies on DNA storage have not included data for 
DNA created from crude methodologies such as one of the ones we used.
Our evaluation took place over 64 weeks with treated samples stored at both 25°C and 50°C. 
High temperature stress allowed us to induce accelerated DNA aging according to the 
Arrhenius law (16). This gave us the ability to evaluate the products for the equivalent of 
nearly seven years. Our results show that both crude and clean preparations of bacterial 
DNA stored dried with either product maintain integrity for downstream PCR applications 
for this length of time.
We used two measures to evaluate the effectiveness of the aforementioned stabilization 
reagents: DNA yield and the Ct values from two qPCR assays that detect the S. pneumoniae 
genes lytA and psaA (17). These tests were chosen because they represent measures that will 
show whether or not the treated DNA would be of sufficient quantity and quality to be 
detected in our usual assays. Our need for ambient stability products will be to store DNA 
extracts from bacterial and viral organisms in high concentrations and for long periods of 
time for use in PCR, qPCR, and sequencing assays. When compared with time 0, DNA yield 
was similar over time for samples stored at room temperature indicating there was no loss in 
total DNA in the samples.
With one exception, samples stored dried with either stability product had no change in Ct 
value over time similar to samples stored in our usual manner, −30°C. The single exception 
gave a Ct range of 3.1 cycles, just over the cutoff for no difference. It is not clear why that 
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one group of samples would show a change, but it is unlikely due to a problem with the 
biostability product but rather an issue with the test process at one of the time points. As a 
control, we also dried samples, stored them at room temperature, but did not add a 
stabilizing matrix. These samples had Ct ranges that show this storage method does not 
adequately maintain DNA quality for downstream testing. Interestingly, clean preparation 
samples stored in this manner fared worse than crude preparation samples. Although it is 
unclear why this would be so, it is possible the crude preparation samples contained 
substances that, upon drying, partially protected the DNA. Those substances were likely 
removed in the process of creating the clean preparations.
This study has two limitations. The first is that it may not be generalizable to other 
applications that use stored DNA. Earlier we described our need for DNA stability products 
and how we typically use DNA extracts. The assays we use amplify short segments (100 – 
500 bp) of single genes which we know are more likely to remain intact while longer 
segments may degrade. We did not test for overall DNA degradation which may be 
important to other laboratories storing and testing DNA from other sources or for other 
purposes. However, other studies have shown the usefulness of these two products using a 
variety of different testing parameters and starting material (7–13). We believe our data add 
to the literature and will be useful to laboratories who may be considering a transition to 
ambient storage protocols. Second, this study was originally intended as a nested study 
within a larger agency-wide study, thus we chose only five samples for testing in our 
laboratory. Unfortunately, issues beyond our control prevented the larger study from being 
completed and we are left with a small sample size. However, we believe the stability of the 
measures over time, even in this small sample size, is worthy of adding to the body of 
literature on this subject. Additionally, there are similar studies of biostability products that 
also have small sample sizes (8, 9, 12, 13, 19).
In summary, our data show DNAstable® Plus and GenTegra® DNA can protect both crude 
and clean preparations of dried bacterial DNA stored at room temperature with similar 
effectiveness as the same DNA samples stored at −30°C. Our accelerated aging experiments 
show that dried DNA can be preserved with these products for at least 6 years and 11 
months.
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FIG. 1. 
Specimen processing and testing workflow.
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Table 1.
Room temperature equivalent of storage at 50°C.
Actual storage time at 50°C Room temperature equivalent
1 week 5.6 weeks
2 weeks 11.3 weeks
4 weeks 22.6 weeks
8 weeks 45.2 weeks
16 weeks 90.5 weeks
32 weeks 180.9 weeks
64 weeks 362.0 weeks
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